Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „repaglinide“
Suchtreffer
Begriffe & Kennungen
Enyglid · 4.5 · When these medications are administered to or withdrawn from a patient receiving repaglinide, the patient shou
Eintrag öffnenEnyglid · 4.8 · Based on the experience with repaglinide and with other hypoglycaemic medicinal products the following adverse
Eintrag öffnenExjade · 4.5 · 11 Interaction with repaglinide and other agents metabolised by CYP2C8 In a healthy volunteer study, the conco
Eintrag öffnenExjade · 4.5 · 31 Interaction with repaglinide and other agents metabolised by CYP2C8 In a healthy volunteer study, the conco
Eintrag öffnenGrepid · 4.5 · CYP2C8 substrate medicinal products: Clopidogrel has been shown to increase repaglinide exposure in healthy vo
Eintrag öffnenIfirmacombi · 4.5 · Repaglinide: Irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenIfirmasta (previously Irbesartan Krka) · 4.5 · Repaglinide: Irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenIrbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop) · 4.5 · Repaglinide Irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesar
Eintrag öffnenIrbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop) · 4.5 · Repaglinide Irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesar
Eintrag öffnenIrbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop) · 4.5 · Repaglinide Irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesar
Eintrag öffnenIrbesartan Teva · 4.5 · 5 Repaglinide Irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbes
Eintrag öffnenIrbesartan Zentiva (previously Irbesartan Winthrop) · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenIrbesartan Zentiva (previously Irbesartan Winthrop) · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenIrbesartan Zentiva (previously Irbesartan Winthrop) · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenIrbesartan/Hydrochlorothiazide Teva · 4.5 · Repaglinide Irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesar
Eintrag öffnenIscover · 4.5 · CYP2C8 substrate medicinal products: Clopidogrel has been shown to increase repaglinide exposure in healthy vo
Eintrag öffnenKarvea · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenKarvea · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenKarvea · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenKarvea · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnen